Paul Bisaro, Executive Chairman at Amneal Pharmaceuticals, Inc. (AMRX), bought 17,000 shares at $11.97 ($203K) on 2019-03-12, disclosed to the SEC on 2019-03-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| MNK | BUY | 2023-03-16 | $42K | — | Filing → |
| TXMD | BUY | 2021-08-18 | $40K | — | Filing → |
| TXMD | BUY | 2020-06-08 | $114K | — | Filing → |